Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Avis
CAR
$4.9B
| $4.09M | ﹤0.01% |
127,354
+10,094
| +9% | +$337K |
|
|
JWN
2002
CALL
DELISTED
Nordstrom
JWN
| $4.08M | ﹤0.01% |
68,300
+4,000
| +6% | +$229K |
|
|
XNET
2003
Xunlei
XNET
$321M
| $4.08M | ﹤0.01% |
561,804
-58,600
| -9% | -$583K |
|
2004
Antero Resources
AR
$11.4B
| $4.08M | ﹤0.01% |
230,177
+78,017
| +51% | +$1.51M |
|
2005
Supernus Pharmaceuticals
SUPN
$2.74B
| $4.08M | ﹤0.01% |
80,943
+56,081
| +226% | +$2.77M |
|
2006
Kite Realty
KRG
$5.29B
| $4.07M | ﹤0.01% |
244,647
+67,511
| +38% | +$1.14M |
|
2007
RH
RH
$3.47B
| $4.07M | ﹤0.01% |
31,077
+21,761
| +234% | +$3.05M |
|
2008
TriNet
TNET
$3.09B
| $4.07M | ﹤0.01% |
72,288
+21,036
| +41% | +$1.18M |
|
2009
CALL
Centene
CNC
$32.9B
| $4.07M | ﹤0.01% |
56,200
-343,400
| -86% | -$23.8M |
|
|
ZGNX
2010
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $4.07M | ﹤0.01% |
82,000
-122,700
| -60% | -$6.25M |
|
|
GWR
2011
DELISTED
Genesee & Wyoming Inc.
GWR
| $4.06M | ﹤0.01% |
44,604
+35,826
| +408% | +$3.11M |
|
|
CYBR
2012
DELISTED
CyberArk
CYBR
| $4.06M | ﹤0.01% |
50,801
+20,693
| +69% | +$1.45M |
|
2013
ICU Medical
ICUI
$4.56B
| $4.05M | ﹤0.01% |
14,338
-20,170
| -58% | -$5.91M |
|
2014
Sabra Healthcare REIT
SBRA
$5.28B
| $4.04M | ﹤0.01% |
174,759
+119,417
| +216% | +$2.71M |
|
|
JJN
2015
DELISTED
iPath Series B Bloomberg Nickel Subindex Total ReturnSM ETN
JJN
| $4.04M | ﹤0.01% |
+240,000
| New | +$4.27M |
|
2016
CALL
Vodafone
VOD
$36.4B
| $4.03M | ﹤0.01% |
185,900
+1,300
| +0.7% | +$30.2K |
|
2017
CALL
Northrop Grumman
NOC
$82.1B
| $4.03M | ﹤0.01% |
12,700
-7,100
| -36% | -$2.16M |
|
2018
CALL
Ralph Lauren
RL
$24.2B
| $4.03M | ﹤0.01% |
29,300
+3,400
| +13% | +$453K |
|
|
UNIT
2019
PUT
Uniti Group
UNIT
$2.28B
| $4.03M | ﹤0.01% |
+200,000
| New | +$3.96M |
|
2020
CALL
Marriott International
MAR
$90.9B
| $4.03M | ﹤0.01% |
30,500
+3,100
| +11% | +$396K |
|
2021
PUT
The Mosaic Company
MOS
$7.46B
| $4.02M | ﹤0.01% |
123,800
-6,000
| -5% | -$181K |
|
2022
Black Hills Corp
BKH
$5.62B
| $4.02M | ﹤0.01% |
69,160
+21,429
| +45% | +$1.29M |
|
2023
Idacorp
IDA
$8.08B
| $4.02M | ﹤0.01% |
40,505
+33,596
| +486% | +$3.24M |
|
2024
AGCO
AGCO
$7.06B
| $4.01M | ﹤0.01% |
65,940
-55,702
| -46% | -$3.37M |
|
2025
MKS Inc
MKSI
$19.8B
| $4.01M | ﹤0.01% |
50,007
-53,394
| -52% | -$4.88M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.